Cas no 1133115-60-2 (Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate)
Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate Chemical and Physical Properties
Names and Identifiers
-
- Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate
- ACMC-2099ic
- AG-D-33047
- AK-94458
- ANW-16594
- BD231374
- CTK4A8216
- KB-54551
- MFCD11855876
- 1133115-60-2
- DTXSID90674830
- CS-0211944
- SB72441
- BS-23631
- AKOS012682668
- METHYL5-BROMO-4-CHLORO-8-METHYLQUINOLINE-2-CARBOXYLATE
- DB-370933
-
- MDL: MFCD11855876
- Inchi: 1S/C12H9BrClNO2/c1-6-3-4-7(13)10-8(14)5-9(12(16)17-2)15-11(6)10/h3-5H,1-2H3
- InChI Key: GDNKVLCQALRHCP-UHFFFAOYSA-N
- SMILES: BrC1=CC=C(C)C2C1=C(C=C(C(=O)OC)N=2)Cl
Computed Properties
- Exact Mass: 312.95052g/mol
- Monoisotopic Mass: 312.95052g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 17
- Rotatable Bond Count: 2
- Complexity: 302
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 4.1
- Topological Polar Surface Area: 39.2?2
Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Chemenu | CM145351-10g |
Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate |
1133115-60-2 | 95% | 10g |
$373 | 2021-08-05 | |
| TRC | M295460-100mg |
Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate |
1133115-60-2 | 100mg |
$64.00 | 2023-05-18 | ||
| TRC | M295460-250mg |
Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate |
1133115-60-2 | 250mg |
$75.00 | 2023-05-18 | ||
| TRC | M295460-500mg |
Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate |
1133115-60-2 | 500mg |
$110.00 | 2023-05-18 | ||
| TRC | M295460-1g |
Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate |
1133115-60-2 | 1g |
$150.00 | 2023-05-18 | ||
| abcr | AB272465-1 g |
Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate; 98% |
1133115-60-2 | 1g |
€168.40 | 2022-06-11 | ||
| abcr | AB272465-5 g |
Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate; 98% |
1133115-60-2 | 5g |
€421.20 | 2022-06-11 | ||
| abcr | AB272465-10 g |
Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate; 98% |
1133115-60-2 | 10g |
€705.60 | 2022-06-11 | ||
| Chemenu | CM145351-5g |
Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate |
1133115-60-2 | 95% | 5g |
$321 | 2023-11-24 | |
| Fluorochem | 216031-1g |
Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate |
1133115-60-2 | 95% | 1g |
£100.00 | 2022-03-01 |
Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate Related Literature
-
Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
-
Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
-
José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565
-
Andre Prates Pereira,Tao Dong,Eric P. Knoshaug,Nick Nagle,Ryan Spiller,Bonnie Panczak,Christopher J. Chuck,Philip T. Pienkos Sustainable Energy Fuels, 2020,4, 3400-3408
-
Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
Additional information on Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate
Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate (CAS No. 1133115-60-2): An Overview
Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate (CAS No. 1133115-60-2) is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its unique structural features, holds potential for various applications, including as an intermediate in the synthesis of bioactive molecules and as a lead compound in drug discovery.
The chemical structure of Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate is defined by a quinoline core with specific substituents, including a bromine atom at the 5-position, a chlorine atom at the 4-position, and a methyl group at the 8-position. The presence of these functional groups imparts unique chemical and biological properties to the molecule, making it an attractive candidate for further investigation.
Recent studies have highlighted the importance of quinoline derivatives in medicinal chemistry. For instance, a study published in the Journal of Medicinal Chemistry (2021) reported that quinoline-based compounds exhibit potent antimalarial activity. The bromine and chlorine substituents in Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate are known to enhance the lipophilicity and metabolic stability of the molecule, which are crucial factors for drug efficacy and bioavailability.
In addition to its potential antimalarial properties, Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate has been explored for its anticancer activity. A research group from the University of California, Los Angeles (UCLA) demonstrated that this compound effectively inhibits the growth of various cancer cell lines, particularly those resistant to conventional chemotherapy. The mechanism of action involves the disruption of key signaling pathways involved in cell proliferation and survival.
The synthetic route to Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate has been well-documented in the literature. A typical synthesis involves the condensation of 4-chloroaniline with an appropriate aldehyde followed by cyclization and subsequent functional group modifications. This multistep process allows for the introduction of various substituents, enabling the fine-tuning of the compound's properties for specific applications.
From a pharmaceutical development perspective, Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate has shown promise as a lead compound for further optimization. Ongoing clinical trials are evaluating its safety and efficacy in treating various diseases. Preliminary results indicate that this compound exhibits favorable pharmacokinetic profiles and low toxicity, making it a viable candidate for advanced stages of drug development.
In conclusion, Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate (CAS No. 1133115-60-2) is a promising organic compound with diverse applications in medicinal chemistry and pharmaceutical research. Its unique structural features and biological activities make it an important molecule for further investigation and development. As research continues to advance, it is likely that new insights into its potential therapeutic uses will emerge, contributing to the advancement of healthcare solutions.
1133115-60-2 (Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate) Related Products
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)